SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-022325
Filing Date
2019-04-30
Accepted
2019-04-30 14:42:39
Documents
1
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv520075_form3.html 3  
1 FORM 3 tv520075_form3.xml 3 1492
  Complete submission text file 0001144204-19-022325.txt   2889
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKORN, INC. 1925 WEST FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address
Moore Thomas Gregory (Reporting) CIK: 0001765700 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38114 | Film No.: 19780735